Sai Life Sciences Achieves EcoVadis Platinum Rating, Joining the Top 1% of Companies Assessed Worldwide
NiveshIQ
NSE: SAILIFE · Healthcare
Sai Life Sciences Ltd.
₹1,315.90▲ ₹15.40 (+1.18%)
Price Chart · Daily closes
1Y
6M
3M
1M
1W
1D
⚡ Intelligence Signals
5 active
🟢 Bullish Earnings Catalyst
📊 RS Laggard (5D)
🔄 Sector Sweep
⚡ Signals Aligned
📉 Pullback
NiveshIQ has detected 5 active signals on SAILIFE. Sign up free to see what each signal means and how it affects the stock.
Unlock signals — freeExpected Move
1D / 1W / 1M range derived from news, fundamentals & technicals
1 Day
±1.8%
1 Week
±4.2%
1 Month
±9.6%
Confidence Score
Based on historical directional & magnitude accuracy for this stock
74
/ 100
About Sai Life Sciences Ltd.
Sai Life Sciences Limited (SAILIFE) is a leading contract research, development, and manufacturing organization (CRDMO) in India and internationally. The company provides a range of services including medicinal chemistry, pharmacokinetics, manufacturing, and contract development, leveraging its expertise to support the pharmaceutical and biotechnology industries. With a strong presence in India and a growing global footprint, Sai Life Sciences Limited has established itself as a trusted partner for clients seeking high-quality research and development services. The company's recent achievement of an EcoVadis Platinum Rating, joining the top 1% of companies assessed worldwide, underscores its commitment to sustainability and excellence. Additionally, the company has announced a talent acqui
Financial Highlights
| Metric | FY24 | FY25 | FY26 |
|---|---|---|---|
| Revenue | ₹1,465 Cr +20.40% | ₹1,696 Cr +15.80% | ₹2,192 Cr +29.30% |
| EBITDA Margin | 26.85% | 23.94% | 31.03% |
| Net Profit | ₹83.00 Cr +730.00% | ₹170.00 Cr +104.80% | ₹348.91 Cr +105.20% |
| EPS | – | ₹6.83 | ₹16.63 |
Annual figures in Indian Rupees (Crores). Source: BSE filings.
Recent News
Sai Life Sciences Achieves EcoVadis Platinum Rating, Joining the Top 1% of Companies Assessed Worldwide
Sai Life Sciences obtient la note Platine décernée par EcoVadis et rejoint ainsi le top 1 % des entreprises les mieux notées à l’échelle mondiale
🔒
+ 3 more stories about Sai Life Sciences Ltd.
Full news feed with AI impact summaries, synced in real time.
Sign up free — it's instantStrategic Outlook
- Q4FY26 results: revenue ₹602 Cr, PAT ₹104 Cr, EPS ₹4.93, EBITDA margin 31.9%. Growth context: revenue YoY +3.8%, PAT YoY +18.5%, revenue QoQ +8.3%, PAT QoQ +4.2%. Street verdict: inline, revenue surprise -1.7%, PAT surprise -1.6%.
Management commentary highlights new capacity additions, capex deployment, and order wins as key near-term growth driver...
FY26 (last completed FY): revenue ₹2, 192 Cr, PAT ₹349 Cr, EBITDA margin 31.0%, EPS ₹16.63. Year-on-year: revenue YoY +2...
🔒
+ 3 more outlook points
Growth drivers, key risks, and upcoming catalysts — unlocked free.
Sign up free — it's instantEverything you unlock with a free account
⚡Intelligence Signals — AI-detected patterns across news, earnings & technicals
📈Price Chart — 1D to 1Y daily closes for SAILIFE
🎯Expected Move — 1D / 1W / 1M range from news, fundamentals & technicals
🧠Confidence Score — Historical directional & magnitude accuracy for this stock
🎙Analyst Target Price — Consensus target with buy / hold / sell breakdown
📰Full News Feed — All stories synced in real time with AI impact summaries
🔭Strategic Outlook — Growth drivers, risks & upcoming catalysts
📊Watchlist & Portfolio — Track SAILIFE alongside your other holdings
Unlock full SAILIFE research — free
No credit card · No trial · Always free to start
Frequently Asked Questions
What AI signals does NiveshIQ provide for Sai Life Sciences Ltd.?
NiveshIQ detects active intelligence signals for Sai Life Sciences Ltd. (SAILIFE) — including earnings catalysts, relative strength patterns, sector sweeps, and pullback setups. It also shows an Expected Move (1D/1W/1M range based on news, fundamentals and technicals) and a Confidence Score based on historical directional and magnitude accuracy. These are exclusive to NiveshIQ.
What are the key financials for Sai Life Sciences Ltd.?
Sai Life Sciences Ltd. operates in the Healthcare sector with a market capitalisation of ₹2,700,490.3L Cr. Revenue, net profit, EPS and EBITDA margins across the last three annual periods are shown above, sourced from BSE filings.
Does NiveshIQ provide investment advice?
No. NiveshIQ provides educational market intelligence and research context, not investment advice or buy/sell recommendations.